Alnylam and Collaborators Publish Research on a new Class of Chemically Modified RNAi Therapeutics

News   Nov 04, 2008

 
Alnylam and Collaborators Publish Research on a new Class of Chemically Modified RNAi Therapeutics
 
 
 

RELATED ARTICLES

Schizophrenics' Blood Contains RNA From More Microbes

News

The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.

READ MORE

Faulty Gene Leads to Alcohol-Induced Heart Failure

News

A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.

READ MORE

Bicycle Therapeutics Expands Strategic Partnership with AstraZeneca

News

New programs added in respiratory and cardio-metabolic diseases.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy